Pharmaceutical companies in India
Pharmaceutical companies in India

Study reveals HbA1c level increased in Mumbai

6 122
Dr. Siddarth N. Shah, Diabetologist

 DTMT Network
MUMBAI : Novo Nordisk Education Foundation (NNEF) has unveiled the first-year report of it's ''Impact India: 1000-Day Challenge'' programme. The program was launched a year ago, to address the issue of suboptimally controlled diabetes in India.

According to the report, HbA1c level, the best recommended indicator of long-term blood sugar control, increased from 8.10% to 8.25% in Mumbai.

Around 56,000 people with an average age of 56 years were part of the analysis in the city, out of which 52% were male and 48% were female.

Dr. Siddarth N. Shah, Diabetologist from Mumbai, said, “The latest India Diabetes Care Index report revealed that the average HbA1c level in the city has increased, which is alarming. If people living with diabetes become more careful about their diet, have adequate physical activity, timely medications and monitor sugar levels regularly, diabetes can be managed effectively.”

Dr. Anil Shinde, Trustee, NNEF said, “With the Impact India initiative, we have set an ambitious target and hope to see India emerge as a role model in diabetes care. The programme was introduced to address the growing concern of uncontrolled diabetes in India.”

The ambition of the programme is to reduce the national average HbA1c by 1%, which can help reduce the risk of diabetes-related complications significantly in India. Under the programme, digital platforms are being leveraged to partner with healthcare practitioners (doctors and paramedics) to evolve and implement an approach to diabetes care appropriate for India.


0 Comments

  1. Be first to post your comments

Your Comment

Your email address will not be published. Required fields are marked *

4+9

Back to Top